The relationship of pentraxin-3 levels with IL-17, fetuin-A, insulin in patients with Behcet's disease

Abstract

Conclusions: Similar to CRP, PTX-3 is an acute-phase reactant that is considered an inflammatory and atherosclerotic biomarker. This study showed that PTX-3 levels can increase, similar to IL-17, but no relationship was detected between disease activity and coronary risk factors such as serum lipids, glucose intolerance and obesity. This was a cross-sectional study; therefore, the patients should be followed in long-term studies to determine whether higher PTX levels in BD patients are associated with a higher incidence of cardiovascular disease. Copyright (C) 2017, Taiwanese Dermatological Association. Published by Elsevier Taiwan LLC.